![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Nordamerika-Marktprognose für menschliche Lebermodelle bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Typ (Leberorganoide, Leber-auf-einem-Chip, 2D-Modelle, 3D-Bioprinting und andere), Anwendung (Arzneimittelentwicklung, Bildung und andere). ) und Endbenutzer (Pharma- und Biotechnologieunternehmen, Forschungsinstitute und andere)
TIPRE00026113 |
Pages: 98 |
Biotechnology |
Nov 2021
|
Type: Regional |
Status: Published
Der nordamerikanische Markt für menschliche Lebermodelle wird voraussichtlich von 98.522,08 Tausend US-Dollar im Jahr 2021 auf 2.08.998,55 Tausend US-Dollar im Jahr 2028 wachsen; Von 2021 bis 2028 wird ein durchschnittliches jährliches Wachstum von 11,3 % erwartet.\\n\\nDie USA, Kanada und Mexiko sind Volkswirtschaften in Nordamerika. Es wird erwartet, dass die steigende Prävalenz von Lebererkrankungen das Wachstum des Marktes für menschliche Lebermodelle in Nordamerika ankurbeln wird. Die Leber ist das größte innere Organ des Körpers und erfüllt über 500 Funktionen. Die Lebertoxizität ist ein Hauptanliegen bei der Risikobewertung, da die Leber den meisten xenobiotischen Verbindungen und ihren bioaktiven Metaboliten ausgesetzt ist und dadurch anfällig für chemisch induzierte Lebererkrankungen ist. Das Hepatitis-C-Virus (HCV), das chronische Hepatitis-B-Virus (HBV), die nichtalkoholische Fettlebererkrankung (NAFLD) und die alkoholassoziierte Lebererkrankung (ALD) gehören zu den Hauptursachen für chronische Lebererkrankungen. Virushepatitis ist nach wie vor die häufigste Todesursache durch Leberversagen, und gleichzeitig ist die NAFLD zu einer der am schnellsten wachsenden Ursachen für Lebermorbidität und damit verbundene Mortalität geworden. Chronische Lebererkrankungen wie NAFLD oder chronische Hepatitis-Infektionen sind mit einem erhöhten Risiko für primären Leberkrebs, das sogenannte hepatozelluläre Karzinom (HCC), verbunden. Leberzirrhose ist bekannt und mit einer Inzidenz von etwa 0,5 Millionen und einer Häufigkeit von 5 Millionen die häufigste Ursache für HCC -Jahres-Überlebensrate von 10 %. Jüngsten Schätzungen zufolge hat die Inzidenz dieser Krebsart alarmierend zugenommen, so dass HCC die fünfthäufigste Krebserkrankung bei Männern und die siebthäufigste Krebserkrankung bei Frauen ist. Das HCC trägt wahrscheinlich zu ~ bei Das HCC ist bekanntermaßen die zweithäufigste krebsbedingte Todesursache in der Region. Weitere Arten von Leberkrebs sind das cholangiozelluläre Karzinom (CCC), eine bösartige Erkrankung der Leber Lebergallengänge und Hepatoblastom. Das Hepatoblastom ist der häufigste bösartige Tumor der Leber bei Kindern. Daher erhöht ein Anstieg der Prävalenz von Lebererkrankungen, einschließlich chronischer und akuter Erkrankungen und mikrobieller Infektionen, die Nachfrage nach Lebermodellen in der gesamten Region Nordamerika. \\n\\nNach Angaben der Centers for Disease Control and Prevention (CDC) besteht bei Patienten mit chronischer Lebererkrankung oder mit geschwächtem Immunsystem ein höheres Risiko für schwere Erkrankungen durch COVID-19. Der rasche Anstieg der gemeldeten COVID-19-Fälle in den USA machte weitreichende Änderungen in der Gesundheitsversorgung im ganzen Land erforderlich. Obwohl Organtransplantationen häufig ein medizinischer Notfall sind, hat die wachsende Nachfrage nach und die Nutzung von Krankenhausressourcen die Fähigkeit von Transplantationszentren, diese lebensrettenden Eingriffe durchzuführen, negativ beeinflusst. COVID-19-bedingte Probleme haben Lebertransplantationen in der Region behindert und stellen im erwarteten Zeitraum eine Bedrohung für den Markt für menschliche Lebermodelle dar. \\n\\nMit den neuen Funktionen und Technologien können Anbieter neue Kunden gewinnen und ihre Präsenz in Schwellenmärkten erweitern. Dieser Faktor dürfte den nordamerikanischen Markt für menschliche Lebermodelle antreiben. Es wird erwartet, dass der Markt für menschliche Lebermodelle in Nordamerika im Prognosezeitraum mit einer guten jährlichen Wachstumsrate wachsen wird. \\n\\nUmsatz und Prognose des Marktes für menschliche Lebermodelle in Nordamerika bis 2028 (in Tausend US-Dollar) \\n\\nMarktsegmentierung für menschliche Lebermodelle in Nordamerika \\nNordamerikanischer Markt für menschliche Lebermodelle nach Typ\\n- Leberorganoide\\n- Leber-on- a-chip\\n- 2D-Modelle\\n- 3D-Bioprinting\\n- Andere\\nNordamerikanischer Markt für menschliche Lebermodelle nach Anwendung\\n- Arzneimittelforschung\\n- Bildung\\n- Andere\\nNordamerikanischer Markt für menschliche Lebermodelle nach Endbenutzer\\ n- Pharma- und Biotechnologieunternehmen\\n- Forschungsinstitute \\n- Andere \\nNordamerikanischer Markt für menschliche Lebermodelle, nach Land\\n- USA \\n- Kanada \\n- Mexiko \\nNordamerikanischer Markt für menschliche Lebermodelle – Erwähnte Unternehmen \\n- BioIVT\\n- CELLINK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- ORGANOVO HOLDINGS INC.\\n- THERMO FISHER SCIENTIFIC INC.\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. BioIVT
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America human liver models market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America human liver models market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Related Reports
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000